14.000
+0,00%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +147.2% | +147.8% | 3 / 3 | +92.1% | -2.34 pp | +2.52 pp | +14.6% | 0.02 | 8.16 | 114 | +92,1% | 13,6 | +143,8% | 8.16 | 19.48 | −58,1% |
| Pts | 12 | 12 | 12 | 12 | 4 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 14.000 (close price on 2026-10-19)EPS (TTM): 1.715
Financial charts
1.Revenue & growth
VND bn114Q2/26
1.Revenue & growth
VND bn114Q2/26
2.Profit & growth
VND bn13,0Q2/26
3.Profit mix (Penman)
VND bn52,7Q2/26
4.Margins & cost structure
%28.9%Q2/26
5.Returns & cash cycle
% · days17.6%Q2/26
6.Earnings quality & cash
VND bn101Q2/26
7.Asset structure
VND bn390Q2/26
8.Funding & debt health
VND bn · times390Q2/26
9.Revenue backlog
VND bn5,05Q2/26
10.Valuation
times · %8,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %531Q2/26
Adjusted EPS growth, latest quarter
142%
Average adjusted EPS growth, 3 quarters
146%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26